Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

HemaSphere - ResearchHub

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

X

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Journal

HemaSphere

2572-9241 · Wiley

11 verified public works

Browse all journals →

MEK inhibition achieves robust and durable responses in Erdheim–Chester disease

2026 · 0 citations

Long‐term mutational analysis, clonal metrics, and dynamics in patients with chronic idiopathic neutropenia

2026 · 0 citations

EHA Guidelines on the management of children and adults with hemoglobin SC disease

2026 · 0 citations

Integrating paroxysmal nocturnal hemoglobinuria (PNH) into mainstream hematological curriculum training

2026 · 0 citations

Longitudinal assessments of MRD in high‐risk newly diagnosed transplant‐ineligible multiple myeloma in the BENEFIT study (IFM2020‐05)

2026 · 0 citations

A platform of serially transplantable AML PDX models covering subgroups for which no cell lines exist

2026 · 0 citations

Correction to “Combined inhibition of de novo pyrimidine synthesis and ATR promotes ATF4‐mediated cell death in TP53 ‐deficient ALL”

2026 · 0 citations

SLV‐404, an anti‐RYK antibody–drug conjugate, is effective in Richter transformation patient‐derived xenografts

2026 · 0 citations

Integrating Gaucher disease (GD) into mainstream hematological curriculum training

2026 · 0 citations

One cycle of nelarabine given after induction is well tolerated but does not improve outcome in adults with T‐cell precursor acute lymphoblastic leukemia: Outcome data from the UKALL14 randomized‐controlled trial

2026 · 0 citations

Chemoimmunotherapy‐associated CD20 ( MS4A1 ) resistance mutations in Waldenström macroglobulinemia: Epitope disruption independent of expression with implications for CD20‐directed cellular therapies

2026 · 0 citations

Page 1 of 1